申请人:Sloan-Kettering Institute
For Cancer Research
公开号:EP0071227A1
公开(公告)日:1983-02-09
Beta-glycosyl C-nucleoside compound of the formula (Excluded 2-deazaoxoformycin) and HCL salts thereof
wherein
X is NR10, S or 0
R10 is H or alkyl with 1 to 6 carbon atoms. R, is
or SR8, or OR8 wherein R6, R7 and Re are independently selected from H or alkyl of 1 to 6 carbon atoms; or R2 is H, NH2,
SR12, or OR12 wherein R16, R11 and R12 are independently selected from H or alkyl of 1-6 carbon atoms;
R3 is OH, SR13, or ORg;
R4 is OH, SR14, or OR15;
R9, R13, R14 and R15 are individually selected from C1-C6
alkyl and C1 to C6 acyl;
R5 is OH or H, R's is OH or H with the proviso that at least one of R5 or R'5 is H.
式中β-糖基 C-核苷化合物(不包括 2-脱氧福美胂)及其 HCL 盐
其中
X 是 NR10、S 或 0
R10 是 H 或 1 至 6 个碳原子的烷基。R是
或 SR8,或 OR8,其中 R6、R7 和 Re 独立选自 H 或 1-6 个碳原子的烷基;或 R2 是 H、NH2、
SR12,或 OR12,其中 R16、R11 和 R12 独立选自 H 或 1-6 个碳原子的烷基;
R3 是 OH、SR13 或 ORg;
R4 是 OH、SR14 或 OR15;
R9、R13、R14 和 R15 分别选自 C1-C6
烷基和 C1 至 C6酰基;
R5 是 OH 或 H,R's 是 OH 或 H,但 R5 或 R'5 中至少有一个是 H。